Lymphoproliferative syndrome is characterized by a persistance of stimmulated lymphocytes as apoptosis of these cells is defective. The disorder is characterized by non-malignant accumulation of lymphocytes in various tissues which may induce secodary atoimmune reactions and cancer.
1. |
Sullivan JL et al. (1983) X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. |
2. |
Skare JC et al. (1989) Mapping the mutation causing the X-linked lymphoproliferative syndrome in relation to restriction fragment length polymorphisms on Xq. |
3. |
Skare JC et al. (1989) Linkage analysis of seven kindreds with the X-linked lymphoproliferative syndrome (XLP) confirms that the XLP locus is near DXS42 and DXS37. |
4. |
Harris A et al. (1988) X-linked lymphoproliferative disease: a karyotype analysis. |
5. |
Skare JC et al. (1987) Mapping the X-linked lymphoproliferative syndrome. |
6. |
Harris A et al. (1988) X-linked lymphoproliferative disease: linkage studies using DNA probes. |
7. |
Loeffel S et al. (1985) Necrotizing lymphoid vasculitis in X-linked lymphoproliferative syndrome. |
8. |
Hayoz D et al. (1988) X-linked lymphoproliferative syndrome. Identification of a large family in Switzerland. |
9. |
Steinherz R et al. (1985) X-linked lymphoproliferative syndrome. A new kindred with variable phenotypic expression. |
10. |
Bar RS et al. (1974) Fatal infectious mononucleosis in a family. |
11. |
Hambleton G et al. (1969) Familial lymphoma. |
12. |
Lyon MF et al. (1983) X-linked factor in acquired immunodeficiency syndrome? |
13. |
Sullivan JL et al. (1980) Deficient natural killer cell activity in x-linked lymphoproliferative syndrome. |
14. |
Purtilo DT et al. (1982) Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. |
15. |
Sanger WG et al. (1990) Partial Xq25 deletion in a family with the X-linked lymphoproliferative disease (XLP) |
16. |
None (1981) X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma. |
17. |
Levine PH et al. (1982) The American Burkitt's Lymphoma Registry: eight years' experience. |
18. |
Hamilton JK et al. (1980) X-linked lymphoproliferative syndrome registry report. |
19. |
Williams LL et al. (1993) Correction of Duncan's syndrome by allogeneic bone marrow transplantation. |
20. |
Vowels MR et al. (1993) Brief report: correction of X-linked lymphoproliferative disease by transplantation of cord-blood stem cells. |
21. |
Grierson HL et al. (1993) Evaluation of families wherein a single male manifests a phenotype of X-linked lymphoproliferative disease (XLP). |
22. |
Skare J et al. (1993) Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. |
23. |
Seemayer TA et al. (1995) X-linked lymphoproliferative disease: twenty-five years after the discovery. |
24. |
Arkwright PD et al. (1998) X linked lymphoproliferative disease in a United Kingdom family. |
25. |
Dutz JP et al. (2001) Lymphocytic vasculitis in X-linked lymphoproliferative disease. |
26. |
Ma CS et al. (2006) Selective generation of functional somatically mutated IgM+CD27+, but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. |
27. |
Verhelst H et al. (2007) Limbic encephalitis as presentation of a SAP deficiency. |
28. |
Booth C et al. (2011) X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease. |
29. |
Sneller MC et al. (1997) Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. |
30. |
Rigaud S et al. (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. |
31. |
Worthey EA et al. (2011) Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. |
32. |
Yang X et al. (2012) Clinical and genetic characteristics of XIAP deficiency in Japan. |
33. |
Latour S et al. (2015) XIAP deficiency syndrome in humans. |
34. |
Dziadzio M et al. (2015) Symptomatic males and female carriers in a large Caucasian kindred with XIAP deficiency. |
35. |
Nishida N et al. (2015) Dysgammaglobulinemia Associated With Glu349del, a Hypomorphic XIAP Mutation. |
36. |
Coffey AJ et al. (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. |
37. |
Sumegi J et al. () The molecular genetics of X-linked lymphoproliferative (Duncan's) disease. |
38. |
Brandau O et al. (1999) Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). |
39. |
Nichols KE et al. (2005) Regulation of NKT cell development by SAP, the protein defective in XLP. |
40. |
Snow AL et al. (2009) Restimulation-induced apoptosis of T cells is impaired in patients with X-linked lymphoproliferative disease caused by SAP deficiency. |
41. |
Wang J et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. |
42. |
Zhu S et al. (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. |
43. |
Ma CS et al. (2005) Impaired humoral immunity in X-linked lymphoproliferative disease is associated with defective IL-10 production by CD4+ T cells. |
44. |
Zhao M et al. (2010) A novel XIAP mutation in a Japanese boy with recurrent pancytopenia and splenomegaly. |
45. |
Pachlopnik Schmid J et al. (2011) Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). |
47. |
Purtilo DT et al. (1975) X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). |
48. |
None (1976) Pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome. |
49. |
Purtilo DT et al. (1978) Epstein-Barr virus infections in the X-linked recessive lymphoproliferative syndrome. |
50. |
Provisor AJ et al. (1975) Acquired agammaglobulinemia after a life-threatening illness with clinical and laboratory features of infectious mononucleosis in three related male children. |
51. |
Purtilo DT et al. (1977) Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome. |
52. |
Purtilo DT et al. (1977) Hematopathology and Pathogenesis of the X-linked recessive lymphoproliferative syndrome. |
53. |
Skare J et al. (1992) First prenatal diagnosis of X-linked lymphoproliferative disease. |
54. |
Mulley JC et al. (1992) X-linked lymphoproliferative disease: prenatal detection of an unaffected histocompatible male. |
55. |
Purtilo DT et al. (1991) Methods of detection of new families with X-linked lymphoproliferative disease. |